Transgene Biotek Ltd. (TRABI)
Market Open
16 Oct, 09:47 AM
MSE MSE Primary ₹
2. 55
+0.03
+1.1905%
₹
176.54M Market Cap
- P/E Ratio
- Div Yield
5,754 Volume
0 Eps
₹ 2.52
Previous Close Want to track TRABI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Transgene Biotek Ltd. (TRABI) Statistics
Valuation metrics
Market Cap 176.54M
Enterprise value 187.15M
Trailing P/E (ttm) -11.73
Forward P/E -
PEG ratio 0.43
Price/Sales (ttm) 84.38
Price/Book (mrq) 2.23
Enterprise Value/Revenue 84.38
Enterprise Value/EBITDA -40.41
Overview
Shares outstanding 75.77M
Float 50.61M
Shares short -
% Held by insiders 0.22%
% Held by institutions -
Average volume (10 days) 27.38K
Average volume (90 days) 29.41K
Price summary
52-Week low 1.83
52-Week high 4.35
Beta 0.54
50-Day moving average 2.68
200-Day moving average 2.87
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -7.25%
Operating margin -2.95%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.18%
Income Statement
Revenue (ttm) 2.33M
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -0.29%
Gross profit (ttm) 2.33M
EBITDA -8.84M
Net income to common (ttm) -19.09M
Diluted EPS (ttm) -0.21
Quarterly earnings growth (yoy) -0.29%
Balance Sheet
Total cash (mrq) 564K
Total cash per share (mrq) 0.01
Total debt (mrq) 165M
Total Debt/Equity (mrq) 2.05
Current ratio (mrq) 0.08%
Book value per share (mrq) 1.11
Cash Flow
Cash flow statement 1.93M
Levered free cash flow (LFCF) -6.76M
2026 © Marketlog. All Rights Reserved.
